Cell Therapy Market Report
RA01085
Cell Therapy Market, by End Use (Hospitals & Clinics, Academic & Research Institutes), Therapeutic Area (Malignancies, Musculoskeletal Disorders, Autoimmune Disorders, Dermatology, Others), Cell Type (Stem Cell, Bone Marrow, Blood, Umbilical Cord-Derived, Adipose-Derived Stem Cell, Others, Non-stem Cell), Treatment (Autologous, Allogeneic): Global Opportunity Analysis and Industry Forecast, 2020-2027
Cell Therapy Overview
Cell therapy, also known as cellular therapy, cell transplantation, or cytotherapy, is a form of treatment where living cells are injected, grafted, or implanted into a patient in order to produce a therapeutic effect. As an example, immunotherapy may involve the transplantation of T-cells that can fight cancer cells through cell-mediated immunity or the grafting of stem cells to restore diseased tissues. The primary idea behind cell therapy is to use living cells' therapeutic capacity to encourage tissue regeneration and healing. Cell therapy, which employs a variety of cell delivery techniques, focuses on a number of clinical indications in various organs. As a result, specific ways of action of the drugs differ greatly. However, in recent years, researchers have focused on stem cell and cell transplantation as a viable new treatment method for a number of diseases, notably immunogenic and degenerative conditions.
Global Cell Therapy Market Analysis
The global cell therapy market size was $4,841.6 million in 2022 and is predicted to grow with a CAGR of 16.4%, by generating a revenue of $22,009.1 million by 2032.
COVID-19 Impact on Global Cell Therapy Market
The COVID-19 pandemic had a significant impact on the global cell therapy market. Numerous academic institutions and biotech firms have shifted their attention and financial support to COVID-19-related research, including vaccine and therapy development. The development of cell therapies for other diseases may have temporarily slowed down because of this shift in focus and resources. Due to the burden on the healthcare system and resource reallocation during the pandemic, some patients may have had trouble getting access to cell treatments.
Clinical trials for cell therapies and other treatments are likely to resume once the pandemic situation has improved and healthcare facilities have adjusted to new procedures. Researchers and biotech companies may have overcome the hurdles posed by the outbreak in order to continue their research. The pandemic accelerated regulatory modifications and responses, resulting in the approval of COVID-19 medicines and vaccines. These lessons could lead to more simplified and efficient regulatory procedures for cell therapies and other medical advances.
Potential to Address Unmet Medical Needs to Drive the Market Growth
The cell therapy market is experiencing widespread growth due to various factors. Patients with illnesses that were challenging to treat with conventional medicines now have hope, thanks to cell therapies' potential to meet unmet medical requirements. Unmet medical demands can be met through cell therapy, especially for diseases that were once thought to be incurable. The field of cell therapy has seen significant investment from both the public and private sectors. In order to establish therapeutic applications, comprehend cell biology, and enhance manufacturing procedures, there has been substantial research and development. Collaboration between academic institutions, biotech companies, and pharmaceutical oligopolies has sped up the tempo of research and development in the field of cell therapy.
High Development Costs to Restrain Market Growth
Payment for cell therapies can be a major obstacle for the global cell therapy market growth, particularly if payers are unsure of the long-term therapeutic and financial advantages. As a result, it is challenging to fairly price these cutting-edge treatments while preserving patient access.
Complex manufacturing procedures and stringent quality control standards are frequently needed for cell treatments. The manufacture of cell-based goods may face difficulties with scalability, standardisation, and consistency as a result of these complications. In comparison to conventional medications, cell therapies are very new, and the industry has little expertise in commercialising these therapies. It can be difficult for manufacturers to comprehend price strategies, market access, and reimbursement models.
Expansion into New Indications to Drive Excellent Opportunities
Cell therapy is expected to be used in new disease areas in addition to those presently treated. More companies are expected to enter the cell treatment market, and multinational collaborations are expected to become more common. The development of "off-the-shelf" cell therapies, which do not need to be customised for each patient's cell harvest and manipulation, could streamline the therapeutic process and save expenses. As technology advances and costs decrease, more people may have access to personalised cell-based treatments tailored to their specific ailments. To increase overall treatment effectiveness, cell therapies can be coupled with other medicines such conventional chemotherapy or immunotherapies. This strategy might result in better patient outcomes and more effective care of complicated diseases.
Global Cell Therapy Market Share, by Therapy Type, 2022
The autologous therapies sub-segment accounted for the highest share in 2022. Autologous cell therapies are an instance of personalised medicine, in which care is tailored to the individual requirements of each patient. With this strategy, treatment effectiveness is increased but rejection or severe responses are less likely. Because there is a genetic match between the donor and recipient cells, using a patient's own cells dramatically lowers the chance of immunological rejection during autologous therapies. Since the patient serves as the donor, autologous cell treatments reduce the danger of infection or disease transmission and do not require the use of immunosuppressive medications.
Global Cell Therapy Market Share, by Therapeutic Area, 2022
The oncology sub-segment accounted for the highest market size in 2022. The need for efficient and cutting-edge cancer treatment alternatives is being driven by the rising incidence of cancer worldwide. Certain types of solid tumours and blood malignancies have responded well to cell therapies, in particular CAR-T cell therapies. Given that they involve employing a patient's own immune cells or genetically altered cells for treatment, cell treatments in oncology are frequently created to be personalised for each patient. This individualised strategy improves treatment effectiveness and lessens side effects. A type of immunotherapy known as cell treatments uses the immune system to specifically target cancer cells in the body. Immunotherapy research has made major strides, which have sparked the creation of ground-breaking cell-based therapies.
Global Cell Therapy Market Share, by Region, 2022
The North America cell therapy market accounted for the highest market share in 2022. North America's healthcare system is highly sophisticated, facilitating the study, development, and marketing of cell therapies. Cell treatments, in particular CAR-T cell therapies for cancer, are examples of personalised medicine that are becoming more popular with patients and in the medical community. The high prevalence of chronic diseases in North America has fuelled interest in cell therapies by raising the need for innovative, efficient treatments. Both the public and corporate sectors have made large investments in the study and creation of cell treatments, promoting experimentation and clinical trials in the region.
Competitive Scenario in the Global Cell Therapy Market
Product development and geographic expansion are key strategies adopted by major players functioning in the highly competitive global cell therapy market.
Some of the leading players in the cell therapy market are Novartis AG, Bluebird Bio, Inc., Gilead Sciences, Inc., Takeda Pharmaceutical Company Limited, Bristol-Myers Squibb Company, Atara Biotherapeutics, Johnson & Johnson Services, Inc, JCR Pharmaceuticals Co., Ltd., Dendreon Corp., and Tego Science.
| Aspect | Particulars |
| Historical Market Estimations | 2021 |
| Base Year for Market Estimation | 2022 |
| Forecast Timeline for Market Projection | 2023-2032 |
| Geographical Scope | North America, Europe, Asia-Pacific, and LAMEA |
| Segmentation by Therapy Type |
|
| Segmentation by Therapeutic Area |
|
| Key Companies Profiled |
|
Q1. What is the size of the cell therapy market?
A. The size of the cell therapy market was over $4,841.6 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 16.4% during the forecast period.
Q2. Which are the major companies in the cell therapy market?
A. Takeda Pharmaceutical Company Limited, Bristol-Myers Squibb Company and Johnson & Johnson Services, Inc are some of the key players in the global cell therapy market.
Q3. Which region, among others, possesses greater investment opportunities in the near future?
A. The Asia-Pacific region possesses great investment opportunities for investors to witness the most promising growth in the future.
Q4. What are the strategies opted by the leading players in this market?
A. Product development and geographic expansion are the two key strategies opted by the operating companies in this market.
Q5. Which companies are investing more on R&D practices?
A. Takeda Pharmaceutical Company Limited and Johnson & Johnson Services, Inc are the companies investing more on R&D activities for developing new products and technologies.
-
1. RESEARCH METHODOLOGY
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.5. Market size estimation
1.5.1. Top-down approach
1.5.2. Bottom-up approach
-
2. REPORT SCOPE
2.1. Market definition
2.2. Key objectives of the study
2.3. Report overview
2.4. Market segmentation
2.5. Overview of the impact of COVID-19 on Global Cell Therapy Market
-
3. EXECUTIVE SUMMARY
-
4. MARKET OVERVIEW
4.1. Introduction
4.2. Growth impact forces
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Market value chain analysis
4.3.1. List of raw material suppliers
4.3.2. List of manufacturers
4.3.3. List of distributors
4.4. Innovation & sustainability matrices
4.4.1. Technology matrix
4.4.2. Regulatory matrix
4.5. Porter’s five forces analysis
4.5.1. Bargaining power of suppliers
4.5.2. Bargaining power of consumers
4.5.3. Threat of substitutes
4.5.4. Threat of new entrants
4.5.5. Competitive rivalry intensity
4.6. PESTLE analysis
4.6.1. Political
4.6.2. Economical
4.6.3. Social
4.6.4. Technological
4.6.5. Environmental
4.7. Impact of COVID-19 on Cell Therapy Market
4.7.1. Pre-covid market scenario
4.7.2. Post-covid market scenario
-
5. Cell Therapy Market, By Application
5.1. Overview
5.2 Hospitals & Clinics
5.2.1 Definition, key trends, growth factors, and opportunities
5.2.2 Market size analysis, by region, 2020-2027
5.2.3 Market share analysis, by country, 2020-2027
5.3 Academic & Research Institutes
5.3.1 Definition, key trends, growth factors, and opportunities
5.3.2 Market size analysis, by region, 2020-2027
5.3.3 Market share analysis, by country, 2020-2027
5.4 Research Dive Exclusive Insights
5.4.1 Market attractiveness
5.4.2 Competition heatmap
-
6. Cell Therapy Market, By Polyethylene Inserts
6.1. Overview
6.2 Malignancies
6.2.1 Definition, key trends, growth factors, and opportunities
6.2.2 Market size analysis, by region, 2020-2027
6.2.3 Market share analysis, by country, 2020-2027
6.3 Musculoskeletal Disorders
6.3.1 Definition, key trends, growth factors, and opportunities
6.3.2 Market size analysis, by region, 2020-2027
6.3.3 Market share analysis, by country, 2020-2027
6.4 Autoimmune Disorders
6.4.1 Definition, key trends, growth factors, and opportunities
6.4.2 Market size analysis, by region, 2020-2027
6.4.3 Market share analysis, by country, 2020-2027
6.5 Dermatology
6.5.1 Definition, key trends, growth factors, and opportunities
6.5.2 Market size analysis, by region, 2020-2027
6.5.3 Market share analysis, by country, 2020-2027
6.6 Others
6.6.1 Definition, key trends, growth factors, and opportunities
6.6.2 Market size analysis, by region, 2020-2027
6.6.3 Market share analysis, by country, 2020-2027
6.7 Research Dive Exclusive Insights
6.7.1 Market attractiveness
6.7.2 Competition heatmap
-
7. Cell Therapy Market, By Mice Type
7.1. Overview
7.2 Stem Cell
7.2.1 Definition, key trends, growth factors, and opportunities
7.2.2 Market size analysis, by region, 2020-2027
7.2.3 Market share analysis, by country, 2020-2027
7.3 Bone Marrow
7.3.1 Definition, key trends, growth factors, and opportunities
7.3.2 Market size analysis, by region, 2020-2027
7.3.3 Market share analysis, by country, 2020-2027
7.4 Blood
7.4.1 Definition, key trends, growth factors, and opportunities
7.4.2 Market size analysis, by region, 2020-2027
7.4.3 Market share analysis, by country, 2020-2027
7.5 Umbilical Cord-Derived
7.5.1 Definition, key trends, growth factors, and opportunities
7.5.2 Market size analysis, by region, 2020-2027
7.5.3 Market share analysis, by country, 2020-2027
7.6 Adipose-Derived Stem Cell
7.6.1 Definition, key trends, growth factors, and opportunities
7.6.2 Market size analysis, by region, 2020-2027
7.6.3 Market share analysis, by country, 2020-2027
7.7 Others
7.7.1 Definition, key trends, growth factors, and opportunities
7.7.2 Market size analysis, by region, 2020-2027
7.7.3 Market share analysis, by country, 2020-2027
7.8 Non-stem Cell
7.8.1 Definition, key trends, growth factors, and opportunities
7.8.2 Market size analysis, by region, 2020-2027
7.8.3 Market share analysis, by country, 2020-2027
7.9 Research Dive Exclusive Insights
7.9.1 Market attractiveness
7.9.2 Competition heatmap
-
8. Cell Therapy Market, By Vehicle Type
8.1. Overview
8.2 Autologous
8.2.1 Definition, key trends, growth factors, and opportunities
8.2.2 Market size analysis, by region, 2020-2027
8.2.3 Market share analysis, by country, 2020-2027
8.3 Allogeneic
8.3.1 Definition, key trends, growth factors, and opportunities
8.3.2 Market size analysis, by region, 2020-2027
8.3.3 Market share analysis, by country, 2020-2027
8.4 Research Dive Exclusive Insights
8.4.1 Market attractiveness
8.4.2 Competition heatmap
9. Cell Therapy Market, By Region
9.1 North America
9.1.1 U.S
9.1.1.1 Market size analysis, By Application, 2020-2027
9.1.1.2 Market size analysis, By Polyethylene inserts, 2020-2027
9.1.1.3 Market size analysis, By Mice Type, 2020-2027
9.1.1.4 Market size analysis, By Vehicle Type, 2020-2027
9.1.2 Canada
9.1.2.1 Market size analysis, By Application, 2020-2027
9.1.2.2 Market size analysis, By Polyethylene inserts, 2020-2027
9.1.2.3 Market size analysis, By Mice Type, 2020-2027
9.1.2.4 Market size analysis, By Vehicle Type, 2020-2027
9.1.3 Mexico
9.1.3.1 Market size analysis, By Application, 2020-2027
9.1.3.2 Market size analysis, By Polyethylene inserts, 2020-2027
9.1.3.3 Market size analysis, By Mice Type, 2020-2027
9.1.3.4 Market size analysis, By Vehicle Type, 2020-2027
9.1.4 Research Dive Exclusive Insights
9.1.4.1 Market attractiveness
9.1.4.2 Competition heatmap
9.2 Europe
9.2.1 Germany
9.2.1.1 Market size analysis, By Application, 2020-2027
9.2.1.2 Market size analysis, By Polyethylene inserts, 2020-2027
9.2.1.3 Market size analysis, By Mice Type, 2020-2027
9.2.1.4 Market size analysis, By Vehicle Type, 2020-2027
9.2.2 UK
9.2.2.1 Market size analysis, By Application, 2020-2027
9.2.2.2 Market size analysis, By Polyethylene inserts, 2020-2027
9.2.2.3 Market size analysis, By Mice Type, 2020-2027
9.2.2.4 Market size analysis, By Vehicle Type, 2020-2027
9.2.3 France
9.2.3.1 Market size analysis, By Application, 2020-2027
9.2.3.2 Market size analysis, By Polyethylene inserts, 2020-2027
9.2.3.3 Market size analysis, By Mice Type, 2020-2027
9.2.3.4 Market size analysis, By Vehicle Type, 2020-2027
9.2.4 Spain
9.2.4.1 Market size analysis, By Application, 2020-2027
9.2.4.2 Market size analysis, By Polyethylene inserts, 2020-2027
9.2.4.3 Market size analysis, By Mice Type, 2020-2027
9.2.4.4 Market size analysis, By Vehicle Type, 2020-2027
9.2.5 Italy
9.2.5.1 Market size analysis, By Application, 2020-2027
9.2.5.2 Market size analysis, By Polyethylene inserts, 2020-2027
9.2.5.3 Market size analysis, By Mice Type, 2020-2027
9.2.5.4 Market size analysis, By Vehicle Type, 2020-2027
9.2.6 Rest of Europe
9.2.6.1 Market size analysis, By Application, 2020-2027
9.2.6.2 Market size analysis, By Polyethylene inserts, 2020-2027
9.2.6.3 Market size analysis, By Mice Type, 2020-2027
9.2.6.4 Market size analysis, By Vehicle Type, 2020-2027
9.2.7 Research Dive Exclusive Insights
9.2.7.1 Market attractiveness
9.2.7.2 Competition heatmap
9.3 Asia-Pacific
9.3.1 China
9.3.1.1 Market size analysis, By Application, 2020-2027
9.3.1.2 Market size analysis, By Polyethylene inserts, 2020-2027
9.3.1.3 Market size analysis, By Mice Type, 2020-2027
9.3.1.4 Market size analysis, By Vehicle Type, 2020-2027
9.3.2 Japan
9.3.2.1 Market size analysis, By Application, 2020-2027
9.3.2.2 Market size analysis, By Polyethylene inserts, 2020-2027
9.3.2.3 Market size analysis, By Mice Type, 2020-2027
9.3.2.4 Market size analysis, By Vehicle Type, 2020-2027
9.3.3 India
9.3.3.1 Market size analysis, By Application, 2020-2027
9.3.3.2 Market size analysis, By Polyethylene inserts, 2020-2027
9.3.3.3 Market size analysis, By Mice Type, 2020-2027
9.3.3.4 Market size analysis, By Vehicle Type, 2020-2027
9.3.4 Australia
9.3.4.1 Market size analysis, By Application, 2020-2027
9.3.4.2 Market size analysis, By Polyethylene inserts, 2020-2027
9.3.4.3 Market size analysis, By Mice Type, 2020-2027
9.3.4.4 Market size analysis, By Vehicle Type, 2020-2027
9.3.5 South Korea
9.3.5.1 Market size analysis, By Application, 2020-2027
9.3.5.2 Market size analysis, By Polyethylene inserts, 2020-2027
9.3.5.3 Market size analysis, By Mice Type, 2020-2027
9.3.5.4 Market size analysis, By Vehicle Type, 2020-2027
9.3.6 Rest of Asia-Pacific
9.3.6.1 Market size analysis, By Application, 2020-2027
9.3.6.2 Market size analysis, By Polyethylene inserts, 2020-2027
9.3.6.3 Market size analysis, By Mice Type, 2020-2027
9.3.6.4 Market size analysis, By Vehicle Type, 2020-2027
9.3.7 Research Dive Exclusive Insights
9.3.7.1 Market attractiveness
9.3.7.2 Competition heatmap
9.4 LAMEA
9.4.1 Brazil
9.4.1.1 Market size analysis, By Application, 2020-2027
9.4.1.2 Market size analysis, By Polyethylene inserts, 2020-2027
9.4.1.3 Market size analysis, By Mice Type, 2020-2027
9.4.1.4 Market size analysis, By Vehicle Type, 2020-2027
9.4.2 Saudi Arabia
9.4.2.1 Market size analysis, By Application, 2020-2027
9.4.2.2 Market size analysis, By Polyethylene inserts, 2020-2027
9.4.2.3 Market size analysis, By Mice Type, 2020-2027
9.4.2.4 Market size analysis, By Vehicle Type, 2020-2027
9.4.3 UAE
9.4.3.1 Market size analysis, By Application, 2020-2027
9.4.3.2 Market size analysis, By Polyethylene inserts, 2020-2027
9.4.3.3 Market size analysis, By Mice Type, 2020-2027
9.4.3.4 Market size analysis, By Vehicle Type, 2020-2027
9.4.4 South Africa
9.4.4.1 Market size analysis, By Application, 2020-2027
9.4.4.2 Market size analysis, By Polyethylene inserts, 2020-2027
9.4.4.3 Market size analysis, By Mice Type, 2020-2027
9.4.4.4 Market size analysis, By Vehicle Type, 2020-2027
9.4.5 Rest of LAMEA
9.4.5.1 Market size analysis, By Application, 2020-2027
9.4.5.2 Market size analysis, By Polyethylene inserts, 2020-2027
9.4.5.3 Market size analysis, By Mice Type, 2020-2027
9.4.5.4 Market size analysis, By Vehicle Type, 2020-2027
9.4.6 Research Dive Exclusive Insights
9.4.6.1 Market attractiveness
9.4.6.2 Competition heatmap
10. Competitive Landscape
10.1 Top winning strategies, 2020-2027
10.1.1 By strategy
10.1.2 By year
10.2 Strategic overview
10.3 Market share analysis, 2020-2027
11. Company Profiles
11.1 Kolon Tissue Gene, Inc.
11.1.1 Overview
11.1.2 Business segments
11.1.3 Product portfolio
11.1.4 Financial performance
11.1.5 Recent developments
11.1.6 SWOT analysis
11.2 Osiris Therapeutics, Inc.
11.2.1 Overview
11.2.2 Business segments
11.2.3 Product portfolio
11.2.4 Financial performance
11.2.5 Recent developments
11.2.6 SWOT analysis
11.3 JCR Pharmaceuticals Co. Ltd.
11.3.1 Overview
11.3.2 Business segments
11.3.3 Product portfolio
11.3.4 Financial performance
11.3.5 Recent developments
11.3.6 SWOT analysis
11.4 NuVasive, Inc.
11.4.1 Overview
11.4.2 Business segments
11.4.3 Product portfolio
11.4.4 Financial performance
11.4.5 Recent developments
11.4.6 SWOT analysis
11.5 Stemedica Cell Technologies, Inc.
11.5.1 Overview
11.5.2 Business segments
11.5.3 Product portfolio
11.5.4 Financial performance
11.5.5 Recent developments
11.5.6 SWOT analysis
11.6 Cells for cells
11.6.1 Overview
11.6.2 Business segments
11.6.3 Product portfolio
11.6.4 Financial performance
11.6.5 Recent developments
11.6.6 SWOT analysis
11.7 HolostemTerapieAvanzateS.r.l.
11.7.1 Overview
11.7.2 Business segments
11.7.3 Product portfolio
11.7.4 Financial performance
11.7.5 Recent developments
11.7.6 SWOT analysis
11.8 Mesoblast Ltd.
11.8.1 Overview
11.8.2 Business segments
11.8.3 Product portfolio
11.8.4 Financial performance
11.8.5 Recent developments
11.8.6 SWOT analysis
11.9 Medipost Co., Ltd.
11.9.1 Overview
11.9.2 Business segments
11.9.3 Product portfolio
11.9.4 Financial performance
11.9.5 Recent developments
11.9.6 SWOT analysis
11.10 ANTEROGEN.CO.,LTD.
11.10.1 Overview
11.10.2 Business segments
11.10.3 Product portfolio
11.10.4 Financial performance
11.10.5 Recent developments
11.10.6 SWOT analysis
Personalize this research
- Triangulate with your own data
- Request your format and definition
- Get a deeper dive on a specific application, geography, customer or competitor
- + 1-888-961-4454 Toll - Free
- support@researchdive.com
